Drugs / human cord blood mononuclear cells
human cord blood mononuclear cells
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01742533 | Mar 2012 → Jun 2013 | primary ovarian failure | Shenzhen Beike Bio-Technology Co., Ltd. | Unknown | No outcome recorded |
| Phase 1/2 | NCT01443689 | Jul 2011 → Mar 2013 | — | Shenzhen Beike Bio-Technology Co., Ltd. | Unknown | No outcome recorded |
| Phase 1/2 | NCT01343511 | Mar 2009 → Jun 2010 | autism | Shenzhen Beike Bio-Technology Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human cord blood mononuclear cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01343511 ↗ |
| Known as | CBMNCs | “This non-randomized, open-label, single center phase I/II trial investigated the safety and efficacy of combined transplantation of human cord blood mononuclear cells (CBMNCs)...” PMID 23978163 ↗ Aug 2013 |
| Known as | hCB-MNCs | “Human umbilical cord mesenchymal stem cells (hUCMSCs) and human cord blood mononuclear cells (hCBMNCs) have been shown to have the ability to modulate the immune response and...” NCT01443689 ↗1“Human umbilical cord mesenchymal stem cells (hUC-MSCs) and human cord blood mononuclear cells (hCB-MNCs) have been shown to have the ability to modulate the immune response and...” NCT01343511 ↗ |
| Modality | Cell therapy | “Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism.” PMID 23978163 ↗ Aug 2013 |
| Route | Intrathecal | “Transplantations included four stem cell infusions through intravenous and intrathecal injections once a week.” PMID 23978163 ↗ Aug 2013 |
| Route | Intravenous | “Transplantations included four stem cell infusions through intravenous and intrathecal injections once a week.” PMID 23978163 ↗ Aug 2013 |